- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AKRO
Recent news which mentions AKRO
Nasdaq Tumbles 500 Points, Crude Oil Down Over 1%
September 13, 2022
From Benzinga
Planet Labs, Core & Main And Some Other Big Stocks Moving Higher On Tuesday
September 13, 2022
From Benzinga
US Stocks Open Lower After Inflation Report, Dow Dips 700 Points
September 13, 2022
From Benzinga
What Is Going on With NeuroBo (NRBO) Stock Today?
September 13, 2022
From InvestorPlace
Why Is Akero Therapeutics (AKRO) Stock Up 120% Today?
September 13, 2022
Tickers
AKRO
From InvestorPlace
Peloton's Shake-Up Continues, but This Tiny Stock Doubled Early Tuesday
September 13, 2022
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 13, 2022
From Benzinga
Akero Therapeutics Shares More Than Double After Lead NASH Candidate Aces Mid-Stage Study
September 13, 2022
Tickers
AKRO
From Benzinga
From InvestorPlace
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
September 12, 2022
From Benzinga
From Benzinga
From Benzinga
89 Biggest Movers From Friday
June 21, 2022
From Benzinga
63 Biggest Movers From Yesterday
June 17, 2022
From Benzinga
Akero Therapeutics Shares Surge After Equity Investment From This Famed Large Cap Biopharma
June 16, 2022
From Benzinga
From Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
February 04, 2022
From Benzinga
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
October 20, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 19, 2021
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 10, 2021
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.